Methods to assess in vitro drug release from injectable polymeric particulate systems

被引:230
作者
D'Souza, SS [1 ]
DeLuca, PP [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Fac Pharmaceut Sci, Lexington, KY 40536 USA
关键词
continuous flow; dialysis; in vitro release methods; IVIVC; microspheres; sample and separate; subcutaneous and intramuscular administration;
D O I
10.1007/s11095-005-9397-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This review provides a compilation of the methods used to Study real-time (37 degrees C) drug release from parenteral microparticulate drug delivery systems administered via the subcutaneous or intramuscular route. Current methods fall into three broad categories, viz., sample and separate, flow-through cell, and dialysis techniques. The principle of the specific method employed along with the advantages and disadvantages are described. With the "sample and separate" technique, drug-loaded microparticles are introduced into a vessel, and release is monitored over time by analysis of Supernatant or drug remaining in the microspheres. In the "flow-through cell" technique, media is continuously circulated through a column containing drug-loaded microparticles followed by analysis of the eluent. The "dialysis" method achieves a physical separation of the drug-loaded microparticles front the release media by use of a membrane, which allows for sampling without interference of the microspheres. With all these methods, the setup and sampling techniques seem to influence in vitro released the results are discussed in detail, and criteria to aid in selection of a method are stated. Attempts to establish in vitro-in vivo correlation for these injectable dosage forms are also discussed. It Would be prudent to have ail in vitro test method for microparticles that satisfies compendial and regulatory requirements, is user friend]V, robust, and reproducible, and call be used for quality-control purposes at real-time and elevated temperatures.
引用
收藏
页码:460 / 474
页数:15
相关论文
共 125 条
[81]  
OKADA H, 1994, J CONTROL RELEASE, V28, P121
[82]  
OKADA H, 1995, CRIT REV THER DRUG, V12, P1
[83]   One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate [J].
Okada, H .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :43-70
[84]   The effect of size, charge and cyclization of model peptides on their in vitro release from DL-PLGA microspheres [J].
Okumu, FW ;
Cleland, JL ;
Borchardt, RT .
JOURNAL OF CONTROLLED RELEASE, 1997, 49 (2-3) :133-140
[85]   Controlled release of interleukin-2 from chitosan microspheres [J].
Özbas-Turan, S ;
Akbuga, J ;
Aral, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (05) :1245-1251
[86]   A new preparation method for protein loaded poly(D,L-lactic-co-glycolic acid) microspheres and protein release mechanism study [J].
Park, TG ;
Lee, HY ;
Nam, YS .
JOURNAL OF CONTROLLED RELEASE, 1998, 55 (2-3) :181-191
[87]   IMPORTANCE OF IN-VITRO EXPERIMENTAL CONDITIONS ON PROTEIN RELEASE KINETICS, STABILITY AND POLYMER DEGRADATION IN PROTEIN ENCAPSULATED POLY(D,L-LACTIC ACID-CO-GLYCOLIC ACID) MICROSPHERES [J].
PARK, TG ;
LU, WQ ;
CROTTS, G .
JOURNAL OF CONTROLLED RELEASE, 1995, 33 (02) :211-222
[88]   In-vitro release of diclofenac diethylammonium from lipid-based formulations [J].
Parsaee, S ;
Sarbolouki, MN ;
Parnianpour, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :185-190
[89]   Assessment of drug salt release from solutions, suspensions and in situ suspensions using a rotating dialysis cell [J].
Parshad, H ;
Frydenvang, K ;
Liljefors, T ;
Cornett, C ;
Larsen, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (04) :263-272
[90]   PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics [J].
Peracchia, MT ;
Gref, R ;
Minamitake, Y ;
Domb, A ;
Lotan, N ;
Langer, R .
JOURNAL OF CONTROLLED RELEASE, 1997, 46 (03) :223-231